Pfizer announces Phase 2 trial results for pneumococcal vaccine
By United One News · AI-generated summary of 2 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
- Pfizer has released Phase 2 trial results for its 25-valent pneumococcal vaccine.
- The company shared data regarding the experimental immunization product.
- Further details from the clinical study were not included in the announcement.
Covered by 2 outlets across the spectrum: 0% left, 100% center, 0% right.
How each side framed it
Pfizer’s 25-valent pneumococcal vaccine shows Phase 2 results
Timeline
First to report: Investing Uk (); 2 articles from 2 outlets so far.
Who is covering this story
- Center (2): Investing Uk, Investing Australia
Sources
- Pfizer’s 25-valent pneumococcal vaccine shows Phase 2 results — Investing Uk (center, AI-estimated) ·
- Pfizer’s 25-valent pneumococcal vaccine shows Phase 2 results — Investing Australia (center, AI-estimated) ·